In this study, researchers from the Cochrane Pregnancy and Childbirth Group have reviewed the data of the births of 88,000 women who took part in 140 randomised trials.
All the available evidence were analysed for comparison of the drugs followed by calculation of ranking among them, providing robust effectiveness and side-effect profiles for each drug. Side-effects can include vomiting, high blood pressure and fever.
Dr Gallos said, “Whilst death from postpartum haemorrhage is a rare complication, it is the most common reason why mothers die in childbirth worldwide and happens because a woman’s womb has not contracted strongly enough after birth and results in excessive bleeding.
“Currently, to reduce excessive bleeding at childbirth, the standard practice across the world is to administer to women after childbirth a drug called oxytocin – a uterotonic which contracts the uterus and stimulates contractions to help push out the placenta.
“Our research has highlighted which drugs may be more effective than oxytocin and we hope that this could impact existing recommendations and save mothers lives worldwide.”This Cochrane review is expected to be updated later this year to incorporate the results of some key ongoing studies which will report their findings in coming months, including a large study involving around 30,000 women across 10 different countries comparing the effectiveness of carbetocin versus oxytocin for preventing bleeding in women having a vaginal birth, and a UK-based trial involving more than 6,000 women comparing carbetocin, oxytocin and ergometrine plus oxytocin combination.”
For more information click on the link: 10.1002/14651858.CD011689.pub2